Contact
Please use this form to send email to PR contact of this press release:
Kamada Announces Submission of Application to the U.S. FDA to Manufacture CYTOGAM® at the Company’s Facility in Israel
TO:
Please use this form to send email to PR contact of this press release:
Kamada Announces Submission of Application to the U.S. FDA to Manufacture CYTOGAM® at the Company’s Facility in Israel
TO: